Alpha Tau Medical Ltd. (DRTSW)
0.35
0.05 (16.67%)
At close: Jan 14, 2025, 2:22 PM
0.35
0.00%
After-hours Jan 14, 2025, 02:22 PM EST
undefined% (undefined)
| Bid | 0.27 |
| Market Cap | 24.47M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.56 |
| Volume | 20,285 |
| Avg. Volume (20D) | 0 |
| Open | 0.35 |
| Previous Close | 0.30 |
| Day's Range | 0.28 - 0.38 |
| 52-Week Range | 0.28 - 0.38 |
| Beta | undefined |
About DRTSW
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was fo...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 121
Stock Exchange NASDAQ
Ticker Symbol DRTSW
Website https://www.alphatau.com